Development of an Immunohistochemical Protein Quantification System in Conjunction with Tissue Microarray Technology for Identifying Predictive Biomarkers for Phosphatidylinositol 3-Kinase Inhibitors
スポンサーリンク
概要
- 論文の詳細を見る
The phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in human cancers by gain-of-function mutations of phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) or dysfunction of phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Therefore PI3K is thought to be a promising target for cancer therapy. Many agents targeting PI3K have been developed and some of them have been evaluated in clinical trials. In recent years, development of predictive biomarkers as companion diagnostics for molecular targeted drugs has become an important requirement for clinical development; however, no clinically established biomarkers that predict the efficacy of PI3K inhibitors have been found. We previously reported that expression of phosphorylated Akt determined by immunoblot analysis correlated with the antitumor efficacy of a PI3K inhibitor ZSTK474 in vitro and in vivo, suggesting that it might be used as a predictive biomarker. In this study, to evaluate biomarker candidates in in vivo tumor samples, we developed an immunohistochemical protein detection/quantification system in conjunction with the tissue microarray technology using a panel of 24 human tumor xenografts (JFCR24). We have clearly demonstrated that expression levels of phosphorylated v-akt murine thymoma viral oncogene homolog (Akt) and mitogen-activated protein kinase (MAPK) determined by this system significantly correlated with those determined by immunoblot analysis. As expected, PTEN status correlated with expression of phosphorylated Akt but not MAPK. Finally, we confirmed that phosphorylated Akt levels determined using this system correlated with the in vivo efficacy of ZSTK474. The present results indicate that the immunohistochemical protein detection/quantification system could be used to quantify expression of biomarker proteins in xenografted tumor tissues as well as in human tumor specimens to predict drug efficacy in future clinical trials.
著者
-
Yamori Takao
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer
-
Irimura Tatsuro
Laboratory Of Cancer Biology And Molecular Immunology ; Graduate School Of Pharmaceutical Sciences T
-
Dan Shingo
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Okamura Mutsumi
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Yoshimi Hisashi
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Isoyama Sho
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Seki Mariko
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
関連論文
- Discovery of Phosphatidylinositol 3-Kinase Inhibitory Compounds from the Screening Committee of Anticancer Drugs (SCADS) Library
- 腎癌細胞株における MUC1 mucin の発現と転移能についての検討
- 接触過敏症におけるMGL2を発現する真皮樹状細胞の重要性 (特集 自然免疫における活性化レセプターと阻止レセプター)
- ウイルス感染におけるウイルス表層糖蛋白質O-結合型糖鎖とレクチンの相互作用の重要性 (あゆみ グライコミクスの世界)
- Properties of Blocking and Non-blocking Monoclonal Antibodies Specific for Human Macrophage Galactose-type C-type Lectin (MGL/ClecSF10A/CD301)
- マクロファージの浸潤におけるヘパラナーゼの活性調節機構 : 接着に伴う酵素の集積は活性を制御するか?
- Distribution of MGL1 Binding Sites and MGL1/2-positive Cells in Lymph Nodes during the Sensitization Phase of Contact Hypersensitivity
- S1-1 ムチンとそのカウンターレセプターとしてのレクチン(ムチン,シンポジウム1,第45回日本組織細胞化学会総会・学術集会)
- Fluorescence Labeling of Oligosaccharides Useful in the Determination of Molecular interactions
- ムチンO-グリコシレーションの制御とその生物学的意義
- マクロファージC型レクチンの免疫応答における意義 (特集 糖鎖を認識する免疫分子--特異性と病態への関与) -- (糖鎖によって指令を受けるリンパ球)
- P-317 卵巣癌の増殖および腹膜播種におけるヒアルロン酸の意義
- ムチン糖鎖合成酵素 (糖鎖機能--第3の生命鎖) -- (糖転移酵素遺伝子・糖鎖関連遺伝子)
- YM-216391, a Novel Cytotoxic Cyclic Peptide from Streptomyces nobilis : I. Fermentation, Isolation and Biological Activities
- Pladienolides, New Substances from Culture of Streptomyces platensis Mer-11107 : III. In Vitro and In Vivo Antitumor Activities
- Differential effector mechanisms induced by vaccination with MUC1 DNA in the rejection of colon carcinoma growth at orthotopic sites and metastases
- Isolation of a Novel Gene Showing Reduced Expression in Metastatic Colorectal Carcinoma Cell Lines and Carcinomas
- Absolute Quantification of Four Isoforms of the Class I Phosphoinositide-3-kinase Catalytic Subunit by Real-Time RT-PCR(Communications to the Editor)
- Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary
- ムチンO-グリコシレーションの制御とその生物学的意義
- Identification of Candidate Genes Determining Chemosensitivity to Anti-cancer Drugs of Gastric Cancer Cell Lines
- Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines
- 樹状細胞による抗原提示とMGL2
- Expression of Different Glycoforms of Membrane Mucin (MUC1) and Secretory Mucin (MUC2, MUC5AC and MUC6) in Pancreatic Neoplasms(Prof. K Watanabe Memorial Article)
- Redistribution of selectin counter-ligandes induced by cytokines
- Basic studies on a labeled anti-mucin antibody detectable by infrared-fluorescence endoscopy
- Vital immunostaining of human gastric and colorectal cancers grafted into nude mice: a preclinical assessment of a potential adjunct to videoendoscopy
- Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages
- Identification of JTP-70902, a p15^-inductive compound, as a novel MEK1/2 inhibitor
- Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan
- Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma
- ANTITUMOR EFFICACIES OF ACLACINOMYCIN A BY ORAL ADMINISTRATION
- Redistributions of macrophages expressing the macrophage galactose-type C-type lectin (MGL) during antigen-induced chronic granulation tissue formation
- MUC1 mucin expression in follicular dendritic cells and lymphoepithelial lesions of gastric mucosa-associated lymphoid tissue lymphoma
- MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas
- Expression of Sulfomucins in Normal Mucosae, Colorectal Adenocarcinomas, and Metastases
- Establishment of a Hepatocyte Cell Line Producing Growth-promoting Factors for Liver-colonizing Tumor Cells
- Anticancer and Some Biological Activities of Thiazinotrienomycin B
- Significance of MUC1 mucin expression in clear cell adenocarcinoma of the ovary
- Increased Expression of MUC1 after X-Irradiation
- Increased Expression after X-Irradiation of MUC1 in Cultured Human Colon Carcinoma HT-29 Cells
- Development and Characterization of a Model of Liver Metastasis Using Human Colon Cancer HCT-116 Cells(Highlighted paper selected by Editor-in-chief,Miscellaneous)
- Sesquiterpenoids and Flavonoids from the Aerial Parts of Tithonia diversifolia and Their Cytotoxic Activity
- Characterization of the expression of MUC1 mucin in human colon carcinoma HT29 cells after exposure to X-ray.
- Flowcytometric analysis of MUC 1 mucin production on the cell surface in human carcinoma cell lines
- Expression of sialylated MUC1 in prostate cancer : Relationship to clinical stage and prognosis
- A Novel Monoclonal Antibody Specific for Sialylated MUC1 Mucin
- Diverse Glycosylation of MUC1 and MUC2: Potential Significance in Tumor Immunity
- Expression of Mucin-associated Sulfo-Le^a Carbohydrate Epitopes on Human Colon Carcinoma Cells
- Characterization of Mouse Integrin α3 Subunit Gene^1
- Purification of Nuclear Proteins That Potentially Regulate Transcription of the MUC1 Mucin Gene Induced by a Soluble Factor
- β-Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases
- Muc1 Mucin as a Radiation-Inducible Marker in Colon Carcinoma Cells
- Involvement of cytokines in the skin-to-lymph node trafficking of cells of the monocyte-macrophage lineage expressing a C-type lectin
- Motif-programmed artificial protein induces apoptosis in several cancer cells by disrupting mitochondria
- Anti-tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts
- 癌を拒絶する免疫機構における糖鎖--免疫系により認識されるMUC1ムチンとグリコシレーション (特集 糖鎖を認識する免疫分子--特異性と病態への関与)
- Organ microenvironment plays significant roles through Fas ligand in vaccine-induced CD4^+ T cell dependent suppression of tumor growth at the orthotopic site
- Phosphatidylinositol 3-kinase inhibitors : promising drug candidates for cancer therapy
- Effect of ZSTK474, a Novel Phosphatidylinositol 3-Kinase Inhibitor, on DNA-Dependent Protein Kinase(Pharmacology)
- Effectiveness of combined treatment using X-rays and a phosphoinositide 3-kinase inhibitor, ZSTK474, on proliferation of HeLa cells in vitro and in vivo
- Early activation and interferon-γ production of tumor-infiltrating mature CD27^ natural killer cells
- 腸管マクロファージのMGLを介する共生細菌認識によるIL-10誘導 (特集 腸管における免疫応答の特殊性とその要因)
- ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms
- Toshiaki Osawa : biochemistry of lectins and their applications in immunochemistry and cellular biology
- Potentiation of Bleomycin in Jurkat Cells by Fungal Pycnidione
- Development of an Immunohistochemical Protein Quantification System in Conjunction with Tissue Microarray Technology for Identifying Predictive Biomarkers for Phosphatidylinositol 3-Kinase Inhibitors
- Search for Novel Anti-tumor Agents from Ridaifens Using JFCR39, a Panel of Human Cancer Cell Lines
- Diverse Glycosylation of MUC1 and MUC2: Potential Significance in Tumor Immunity.
- Purification of Nuclear Proteins That Potentially Regulate Transcription of the MUC1 Mucin Gene Induced by a Soluble Factor.